EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-02-03
Management highlights
• Acceleration of affordability initiatives in PFNA during the first half, with surgical investments in specific brands, consumers, and channels. • Productivity gains in the fourth quarter expected to fund commercial plans. • Innovation efforts including restaging large brands like Lay's, Gatorade, and Quaker with focus on simplicity, ingredients, and functionality. • Double-digit space gains in Frito-Lay from March/April as partners reset layouts. • Integration of acquisitions like poppi and Siete into organic growth, with Siete flipping to organic in March and poppi in July. • Response to GLP-1 adoption with focus on portion control, hydration, fiber, and protein innovations. • Testing of food and beverage distribution integration in Texas and Florida, with plans to scale solutions considering regional nuances.
Segment performance
Discussions centered on Frito-Lay North America (PFNA) with mentions of volume growth, net revenue, and double-digit space gains in the main aisle and perimeter. Beverages North America (PBNA) and International segments were also touched upon, with International expected to have mid-single digit growth. PFNA operating margins are expected to expand this year with a combination of affordability initiatives, space gains, and productivity.
Guidance
• Expect sales to strengthen in the second half as initiatives gain traction and acquisitions move into organic growth. • EPS expected to be balanced between first and second halves. • Organic sales acceleration in the second half driven by North America businesses, beverage business acceleration, and M&A integrations turning into organic growth. • Continued focus on improving margins in the beverage business in North America towards target margins.
Risks
• Macro-economic pressures on middle- and low-income consumers affecting affordability. • Competitive pressures in various markets. • Execution challenges in distribution integration, though optimistic about potential value creation. • Uncertainties in macro conditions in key markets like Western Europe and Brazil impacting guidance.
Q&A highlights
Q: Bonnie Herzog from Goldman Sachs asked about PFNA's affordability initiatives, how they're working, price points, and balancing growth and profitability.
A: Steve Schmitt and Ramon Laguarta discussed surgical affordability investments, productivity funding, space gains, and balanced use of productivity to drive sales growth.
Q: Andrea Teixeira from JPMorgan inquired about pricing reinvestment, volume trajectory, and cadence of quarters.
A: Ramon Laguarta and Steve Schmitt talked about surgical price investments, double-digit space gains, and sales strengthening in the second half as initiatives gain traction.
Q: Dara Mohsenian from Morgan Stanley asked about focus on affordability and price investments.
A: Ramon Laguarta elaborated on surgical, tested affordability investments with good ROI and volume return.
Q: Lauren Lieberman from Barclays asked about advertising decline in 2025 and 2026 plans.
A: Steve Schmitt mentioned efficiency in 2025 and growth-minded advertising investment in 2026.
Q: Filippo Falorni from Citi asked about organic sales guidance acceleration drivers.
A: Ramon Laguarta discussed International mid-single digit growth, North America business acceleration, beverage business acceleration, and M&A integrations contributing to organic growth.
Q: Peter Grom from UBS asked about innovation and its impact on North America.
A: Ramon Laguarta talked about core brand restaging, category-building innovation, and portion control as levers for growth.
Q: Kevin Grundy from BNP Paribas asked about GLP-1 adoption implications.
A: Ramon Laguarta discussed portion control, hydration, fiber, protein innovations, and single-serve investments to address GLP-1 impact.
Q: Steve Powers from Deutsche Bank asked about PBNA growth, energy portfolio, and CELSIUS/Alani integration.
A: Ramon Laguarta talked about PBNA margin improvement, energy portfolio growth, CELSIUS brand growth, and Alani integration progress.
Q: Peter Galbo from Bank of America asked about M&A lapping into organic growth.
A: Steve Schmitt mentioned Siete flipping to organic in March and poppi in July, with more acceleration expected.
Q: Chris Carey from Wells Fargo Securities asked about Pepsi and Mountain Dew performance.
A: Ramon Laguarta discussed Pepsi's improvement with no-sugar products and advertising, and Mountain Dew's progress with local marketing and innovation.
Q: Robert Moskow from TD Cowen asked about Texas/Florida distribution tests.
A: Ramon Laguarta talked about integrated delivery, inventory points, and plans to scale solutions considering regional nuances.
Q: Robert Ottenstein from Evercore ISI asked about macro backdrop and its impact on guidance.
A: Ramon Laguarta discussed continuistic guidance based on Q4 data, consumer trends, and market-specific conditions in major markets.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $2.26 | $2.24 | +0.9% | $1.96 |
| Revenue | $29.34B | $28.98B | +1.3% | $27.78B |
Transcript
February 3, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.